commercialization
-
Spine
SpinaFX Hits Key Milestones Since Closing its $6.88M Series A Round
Acquires intellectual property to support pursuit of regulatory approval for innovative treatment TORONTO, May 26, 2022 /PRNewswire/ – Minimally invasive image-guided therapy…
Read More » -
Financial
Carlsmed Raises $30M in Series B Funding to Scale Personalized Spine Surgery
CARLSBAD, Calif.–/OrthoSpineNews/– Carlsmed announced today that it closed an oversubscribed $30M Series B funding round, led by B Capital Group,…
Read More » -
Spine
NanoHive Medical, LLC Closes a Growth Financing Round
BOSTON, MA, April 12, 2022 /OrthoSpineNews/ NanoHive Medical, LLC announced today that the company has closed on an oversubscribed Growth…
Read More » -
Spine
Hyprevention raises $4.5M to accelerate commercialization of the V-STRUT© Vertebral Implant product.
The company has launched a US subsidiary to commercialize the V-STRUT© product. March 2, 2022, OrthoSpineNews – Hyprevention has developed…
Read More » -
Regulatory
MCRA Assists Active Life Scientific with Clinical Study Execution and Successful De Novo Decision for the OsteoProbe – A New Tool to Measure Bone Tissue
– MCRA’s CRO and Regulatory Teams assisted Active Life Scientific, Inc. with integrated regulatory and clinical research services to support…
Read More » -
Extremities
Fuse Medical, Inc. Announces Exclusive Agreement With Orthovestments, LLC for Manufacturing & Commercialization of the Orbitum™ Staple System
February 1, 2021 RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of…
Read More » -
Hospitals
Vuzix Receives Follow-on Smart Glasses Orders from Pixee Medical to Support European Commercialization of their Augmented Reality Smart Glasses Solution for Orthopedic Surgery
ROCHESTER, N.Y., Dec. 2, 2020 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR)…
Read More » -
Robotics
Mazor Robotics and Medtronic Combine Efforts on the Commercialization of Mazor X™: An Innovative Guidance System for Spine Surgery
ORLANDO, Fla., March 17, 2017 /PRNewswire/ — Mazor Robotics Ltd. is a global leader in the development and distribution of…
Read More » -
Spine
VEXIM: another major step towards the SpineJack® commercialization in the US
Toulouse, February 21st, 2017 (8:00AM CET) – VEXIM (FR0011072602 – ALVXM), a medical device company specializing in the minimally-invasive treatment…
Read More » -
Recon
Offering small orthopedic companies a competitive edge — Ortho Sales Partners’ purpose
Written by Megan Wood | Thursday, 15 December 2016 Young companies must overcome innumerable obstacles to introduce a product to…
Read More » -
Spine
INTELLIROD SPINE: $1 MILLION FOR WIRELESS SENSORS
Elizabeth Hofheinz, M.P.H., M.Ed. • Mon, August 1st, 2016 Curious about the strain being put on that spine implant? So…
Read More » -
Financial
Intellirod Spine Raises Over $1M
AKRON, OH–(Marketwired – Jul 26, 2016) – Intellirod Spine, the spinal implant company developing disposable and implantable wireless RFID sensor…
Read More » -
Top Stories
Trice Medical Appoints Mark Foster Chief Commercialization Officer
KING OF PRUSSIA, Pa., July 7, 2016 /PRNewswire/ — Trice Medical today announced the appointment of Mark Foster as chief…
Read More » -
Financial
Histogenics Corporation Acquires NeoCart® Development and Commercialization Rights for Japanese Market
WALTHAM, Mass., May 10, 2016 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and…
Read More » -
Hospitals
GRAFTYS Announces the Extension of its CE Mark for Its Calcium Phosphate Cements to Now Include GRAFTYS® HBS and GRAFTYS® Quickset for the Indication of Subchondral Bone Marrow Lesions around the Knee Joint (BML)
GRAFTYS SA, a company focused on development and commercialization of orthopedic biomaterials, is pleased to announce that it has obtained…
Read More »